Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Jianguo Wen; Wenjing Tao; Isere Kuiatse; Pei Lin; Yongdong Feng; Richard J. Jones; Robert Z. Orlowski; Youli Zu
Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions
Yasuhiro Oki; Michael S. Ewer; Daniel J. Lenihan; Michael J. Fisch; Fredrick B. Hagemeister; Michelle Fanale; Jorge Romaguera; Barbara Pro; Nathan Fowler; Anas Younes; et al.
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label, single arm, phase II trial
Naveen Pemmaraju; Dhaval Shah; Hagop Kantarjian; Robert Z. Orlowski; Graciela M. Nogueras González; Veera Baladandayuthapani; Nitin Jain; Verena Wagner; Guillermo Garcia-Manero; Jatin Shah; et al.
Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia
Myron S. Czuczman; Stephen Kahanic; Andres Forero; Glen Davis; Mihaela Munteanu; Eric Van Den Neste; Fritz Offner; Dominique Bron; Donald Quick; Nathan Fowler
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma
Fu-Ming Zi; Jing-Song He; Yi Li; Cai Wu; Li Yang; Yang Yang; Li-Juan Wang; Dong-Hua He; Yi Zhao; Wen-Jun Wu; et al.
Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
Sattva S. Neelapu
Mutations and microenvironment collude in FL
Robert Z. Orlowski; Liana Gercheva; Cathy Williams; Heather Sutherland; Tadeusz Robak; Tamás Masszi; Vesselina Goranova-Marinova; Meletios A. Dimopoulos; James D. Cavenagh; Ivan Špička; et al.
A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
Jason R Westin
Busting robustness: Using cancer's greatest strength to our advantage
Isabel Leal; Joan Engebretson; Lorenzo Cohen; Alma Rodriguez; Tenzin Wangyal; Gabriel Lopez; Alejandro Chaoul
Experiences of paradox: A qualitative analysis of living with cancer using a framework approach
Xiao Huang; Mengru Cao; Li Wang; Shuhong Wu; Xiaoying Liu; Hongyu Li; Hui Zhang; Rui-Yu Wang; Xiaoping Sun; Caimiao Wei; et al.
Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380
Harrys A. Torres; Parag Mahale; Boris Blechacz; Ethan Miller; Ahmed Kaseb; H. Franklin Herlong; Nathan Fowler; Ying Jiang; Issam I. Raad; Dimitrios P. Kontoyiannis
Effect of hepatitis c virus infection in patients with cancer: Addressing a neglected population
Lan V. Pham; Muychi T. Vang; Archito T. Tamayo; Gary Lu; Pramoda Challagundla; Jeffrey L. Jorgensen; Alex A. Rollo; Zhishuo Ou; Liang Zhang; Michael Wang; et al.
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease
Jessica N. Williams; Ashish Rai; Joseph Lipscomb; Jean L. Koff; Loretta J. Nastoupil; Christopher R. Flowers
Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma
Hexige Saiyin; Christine M Ardito-Abraham; Yanhua Wu; Youheng Wei; Yuan Fang; Xu Han; Jianang Li; Ping Zhou; Qing Yi; Anirban Maitra; et al.
Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma
Kui Shin Voo; Myriam Foglietta; Elena Percivalle; Fuliang Chu; Durga Nattamai; Megan Harline; Seung-Tae Lee; Laura Bover; Heather Y. Lin; Veerabhadran Baladandayuthapani; et al.
Selective targeting of toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma
Haiyan Li; Yong Lu; Jianfei Qian; Yuhuan Zheng; Mingjun Zhang; Enguang Bi; Jin He; Zhiqiang Liu; Jingda Xu; Jerry Y Gao; et al.
Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitro
Farrukh T. Awan; Peter Hillmen; Andrzej Hellmann; Tadeusz Robak; Steven G. Hughes; Denise Trone; Megan Shannon; Ian W. Flinn; John C. Byrd; Dardo Riveros; et al.
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Swaminathan P. Iyer; Joseph Taddeus Beck; A. Keith Stewart; Jatin Shah; Kevin R. Kelly; Randi Isaacs; Sanela Bilic; Suman Sen; Nikhil C. Munshi
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
Rush hour traffic: directing T cells to tumor
June Li; Yasuhiro Kurasawa; Yang Wang; Karen Clise-Dwyer; Sherry A. Klumpp; Hong Liang; Ramesh C. Tailor; Aaron C. Raymond; Zeev Estrov; Stephen J. Brandt; et al.
Requirement for Ssbp2 in hematopoietic stem cell maintenance and stress response